Amphastar Pharmaceuticals, Inc.
(NASDAQ : AMPH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -1.33%57.236.5%$169.22m
CTLTCatalent, Inc. -1.45%78.002.4%$132.70m
VRXValeant Pharmaceuticals International, Inc. 0.29%17.2014.1%$101.21m
JAZZJazz Pharmaceuticals Plc 1.08%106.602.4%$81.66m
UTHRUnited Therapeutics Corp. 0.45%117.4414.3%$68.96m
BHCBausch Health Cos., Inc. 0.29%17.200.0%$68.81m
ICPTIntercept Pharmaceuticals, Inc. 2.80%45.0916.8%$63.68m
PCRXPacira Biosciences, Inc. 0.49%57.8010.3%$55.61m
AXSMAxsome Therapeutics, Inc. 1.37%83.041.9%$51.78m
ZGNXZogenix, Inc. -2.05%27.247.5%$47.44m
PRGOPerrigo Co. Plc 1.68%55.176.8%$45.82m
MYOKMyoKardia, Inc. -0.29%92.861.8%$45.18m
ARGXargenx SE -1.04%250.510.0%$42.94m
GWPHGW Pharmaceuticals Plc -0.16%127.906.2%$38.07m
ICLRICON plc -2.48%169.964.3%$37.43m

Company Profile

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.